Equal opportunity targeting in chronic GVHD

Blood

Volumn 119, Issue 26, 2012, Pages 6183-6184

  Hess, Allan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN RECOGNITION; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; EFFECTOR CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 84863504967     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-425298     Document Type: Note

References (9)

1. Rangarajan H, Yassai M, Subramanian H, et al. Emergence ofTcells that recognize nonpolymorphic antigens during graft-versus-host disease. Blood. 2012;119(26):6354-6364.
2. Santos GW, Hess AD, Vogelsang GB. Graft-versushost reactions and disease. Immunol Rev. 1985;88(1):169-192.
3. Wu JM, Thoburn CJ, Wisell J, Farmer ER, Hess AD. CD20, AIF-1 and TGFbeta in graft-versus-host disease; a study of mRNA expression in histologically matched skin biopsies. Mod Pathol. 2010;23(5):720-728.
4. Parkman R. Clonal analysis of murine graft-versus-host disease. 1. Phenotypic and functional analysis of T lymphocyte clones. J Immunol. 1986;136(10):3543-3548. (Pubitemid 16122043)
5. Kanakry CG, Ganguly S, Meade Bolanos FJ, et al. Post-transplant cyclophosphamide (PT/Cy) preserves effector (T-eff) and regulatory (T-reg)Tcells during early immune reconstitution after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2012;18(2 Suppl 2):224-225.
6. Hess AD, Horwitz L, Beschorner WE, Santos GW. Development of graft-vs-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. J Exp Med. 1985;161(4):718-730. (Pubitemid 15083772)
7. Miura Y, Thoburn CJ, Bright EC, et al. Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD. Blood. 2001;98(3):868-876.
8. Thoburn CJ, Miura Y, Bright EC, Hess AD. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease. Biol Blood Marrow Transplant. 2004;10(9):591-603. (Pubitemid 39157826)
9. Hess AD, Bright EC, Thoburn C, Vogelsang GB, Jones RJ, Kennedy MJ. Specificity of effector T lymphocytes in autologous graft-vs-host disease: role of the major histocompatibility complex class II invariant chain peptide. Blood. 1997;89(6):2203-2209. (Pubitemid 27132139)